Kelly Moynihan, Ph.D.
Kelly Moynihan joined Third Rock in 2017 and currently serves as a senior associate, focusing on new company formation and due diligence. Kelly was involved in the launch of:
- Celsius Therapeutics
Prior to joining Third Rock, Kelly completed her Ph.D. in Biological Engineering at MIT as a Hertz Foundation Fellow, NSF Fellow, and Siebel Scholar. Her thesis focused on designing improved immunotherapies for the treatment of cancer. Prior to that, Kelly received her B.S. in Biomedical Engineering from the University of Texas at Austin.
Kelly has recently taken up urban farming, raising chickens at her home in lower Allston.